1

Zoetis

The world's largest producer of medicine and vaccinations for pets and livestock.

Categories

Pharma and Life Sciences  

#244

Rank

$78.85B

Marketcap

US United States

Country

Zoetis
Leadership team

Heidi Chen (Executive Vice President and, General Counsel)

Glenn David (EVP and Chief Financial Officer)

Industries

Pharma and Life Sciences

Products/ Services
drugs, medicine, vaccinations
Number of Employees
1,000 - 20,000
Headquarters
Parsippany-Troy Hills, 10 Sylvan Way, Parsippany
Established
1952
Company Type
Public Limited Company
Company Registration
SEC CIK number: 0001555280
Net Income
1B - 20B
Revenue
Above - 1B
Traded as
ZTS
Social Media
Overview
Location
Summary

Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm, it is now a completely independent company. 

The company directly markets its products in approximately 45 countries and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.

History

1952: In 1952, the Pfizer Agriculture Division opened a 732-acre research and development facility in Terre Haute, Indiana, called Vigo.

1988: By 1988 the division was renamed Pfizer Animal Health.

1995: The 1995 acquisition of Norden Laboratories from GlaxoSmithKline expanded Pfizer's animal health division into small animal care, including domestic pets.

1997: Actelion profile and corporate video Actelion is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland.

2003: Secondary research and development centres were opened in Kalamazoo, Michigan, in 2003.

2012: At the time, it was the largest IPO from a United States company since Facebook's $16 billion IPO on May 18, 2012. Zoetis was founded in July 2012 and is headquartered in New York, NY.“ Records show that Pfizer officially filed for registration of a Class A stock with the United States Securities and Exchange Commission on August 10, 2012.

2013: Zoetis' IPO on February 1, 2013 sold 86.1 million shares for US$ 2.2 billion. On May 22, 2013, The Wall Street Journal reported that Pfizer planned to sell its majority stake in the company.

2015: In November 2015, the company announced it would acquire a developer of aquaculture treatments and diseases, Pharmaq, for $765 million.

2017: In 2017, Zoetis acquired Ireland-based Nexvet, a company with a biologics focused technology and product candidate pipeline.

2018: In May 2018, the company announced its intention to acquire Abaxis for $1.9 billion in cash.

2019: Excludes revenue associated with Client Supply Services, which represented 1% of total 2019 revenue.

2021: In August 2021, Zoetis announced it would buy Jurox, increasing the business' presence in New Zealand, the US, Canada and the UK.

Mission

According to Zoetis, the company mission is: “to strive every day to put customers first because when they thrive, Zoetis all benefit. Leading the way are Zoetis field representatives, who develop beneficial business relationships with customers that endure for years".

Vision

According to Zoetis, the company vision is: “to build on a six-decade history and singular focus on animal health to bring customers quality products, services and a commitment to their businesses".

Key Team

Roxanne Lagano (Executive Vice President, Chief Human Resources Officer and Global Operations)

Wafaa Mamilli (Executive Vice President - Chief Information and Digital Officer)

Abhay Nayak (Executive Vice President, Head of Strategy)

Jeannette Ferran Astorga (Executive Vice President)

Nick Ashton (Executive Vice President and President)

Robert Polzer (Executive Vice President and President)

Tim Bettington (Executive Vice President and President)

Wetteny Joseph (Executive Vice President and Chief Financial Officer)

Juan Ramón Alaix (Chief Executive Officer)

Recognition and Awards
Forbes Global 2000: Zoetis has been listed on the Forbes Global 2000, recognizing the company as one of the largest public companies in the world. Fortune 500: Zoetis has been listed on the Fortune 500, recognizing the company as one of the largest companies in the United States by revenue. World's Most Admired Companies: Zoetis has been recognized as one of the World's Most Admired Companies by Fortune magazine, based on its reputation for quality, innovation, and corporate responsibility. Top Employers for Diversity: Zoetis has been recognized as a Top Employer for Diversity by Forbes, based on its commitment to creating a diverse and inclusive workplace. Ethisphere World's Most Ethical Companies: Zoetis has been recognized as one of the World's Most Ethical Companies by Ethisphere, based on its commitment to ethical business practices and corporate responsibility. Diversity Best Practices Inclusion Index: Zoetis has been recognized on the Diversity Best Practices Inclusion Index, based on its commitment to diversity and inclusion in the workplace. Best Places to Work for LGBT Equality: Zoetis has been recognized as one of the Best Places to Work for LGBT Equality by the Human Rights Campaign, based on its commitment to LGBT equality and inclusion in the workplace.
Products and Services

Livestock Pharmaceuticals: Zoetis provides pharmaceutical products for the prevention, treatment, and control of diseases in cattle, pigs, poultry, and sheep.

Companion Animal Pharmaceuticals: Zoetis provides pharmaceutical products for the prevention, treatment, and control of diseases in dogs, cats, and horses.

Livestock Vaccines: Zoetis provides vaccines for the prevention of diseases in livestock, including cattle, pigs, poultry, and sheep.

Companion Animal Vaccines: Zoetis provides vaccines for the prevention of diseases in companion animals, including dogs, cats, and horses.

Parasite Control Products: Zoetis provides products for the control of parasites in livestock and companion animals, including flea and tick control products.

Diagnostic Products: Zoetis provides diagnostic products for the early detection and diagnosis of diseases in animals.

Genetic Testing Services: Zoetis provides genetic testing services for livestock and companion animals, including DNA testing for disease susceptibility and for the selection of animals for breeding purposes.

Animal Health Software and Services: Zoetis provides software and services for animal health management, including herd and flock management tools, data analysis and reporting tools, and veterinary consulting services.

References
Zoetis
Leadership team

Heidi Chen (Executive Vice President and, General Counsel)

Glenn David (EVP and Chief Financial Officer)

Industries

Pharma and Life Sciences

Products/ Services
drugs, medicine, vaccinations
Number of Employees
1,000 - 20,000
Headquarters
Parsippany-Troy Hills, 10 Sylvan Way, Parsippany
Established
1952
Company Type
Public Limited Company
Company Registration
SEC CIK number: 0001555280
Net Income
1B - 20B
Revenue
Above - 1B
Traded as
ZTS
Social Media